interest broadband antiinfluenza monoclonal antibody mab recent strengthen identify antihemagglutinin ha endo heterosubtyp neutral active use design universe prophylact therapeutic tool howe major single describe date bind neutral viral iso belong highly divers subtype cluster two differ habeas influenza phylogenetic group group include among other h subtype describe human mab name india capable bind test hn sever first period tandem therefore response report tandem well potent region recon identify stem include reside conserve deep character feature may metres use help improv avail strategy provide new develop vaccine 